Armistice Capital, LLC Shockwave Medical, Inc. Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $68.8 Million - $117 Million	-359,888 Reduced 84.47%	66,169 $21.5 Million
Q4 2023 Feb 13, 2024	BUY	$160.99 - $215.69 $43 Million - $57.6 Million	267,055 Added 167.96%	426,057 $81.2 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $1.75 Million - $2.56 Million	9,002 Added 6.0%	159,002 $31.7 Million
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $23.6 Million - $32.1 Million	-106,000 Reduced 41.41%	150,000 $42.8 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $35.8 Million - $44.5 Million	204,000 Added 392.31%	256,000 $55.5 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $3.27 Million - $4.75 Million	16,000 Added 44.44%	52,000 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $7.03 Million - $11.2 Million	36,000 New	36,000 $10 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.